<b>Role of pituitary adenylyl cyclase-activating polypeptide in intracellular calcium dynamics of neurons and satellite cells in rat superior cervical </b><b>ganglia </b>

  • ISOBE Kanako
    Department of Anatomy (Cell Biology), Iwate Medical University Division of Special Care Dentistry, Department of Developmental Oral Health Science, School of Dentistry, Iwate Medical University
  • YOKOYAMA Takuya
    Department of Anatomy (Cell Biology), Iwate Medical University
  • MORIGUCHI-MORI Kasumi
    Division of Special Care Dentistry, Department of Developmental Oral Health Science, School of Dentistry, Iwate Medical University
  • KUMAGAI Miho
    Division of Special Care Dentistry, Department of Developmental Oral Health Science, School of Dentistry, Iwate Medical University
  • SATOH Yoh-ichi
    Department of Anatomy (Cell Biology), Iwate Medical University Department of Medical Education, Iwate Medical University
  • KUJI Akiyoshi
    Division of Special Care Dentistry, Department of Developmental Oral Health Science, School of Dentistry, Iwate Medical University
  • SAINO Tomoyuki
    Department of Anatomy (Cell Biology), Iwate Medical University

この論文をさがす

抄録

<p>Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a bioactive peptide with diverse effects in the nervous system. The present study investigated whether stimulation of PACAP receptors (PACAPRs) induces responses in neurons and satellite cells of the superior cervical ganglia (SCG), with special reference to intracellular Ca2+ ([Ca2+]i) changes. The expression of PACAPRs in SCG was detected by reverse transcription-PCR. PACAP type 1 receptor (PAC1R), vasoactive intestinal peptide receptor type (VPAC)1R, and VPAC2R transcripts were expressed in SCG, with PAC1R showing the highest levels. Confocal microscopy analysis revealed that PACAP38 and PACAP27 induced an increase in [Ca2+]i in SCG, first in satellite cells and subsequently in neurons. Neither extracellular Ca2+ removal nor Ca2+ channel blockade affected the PACAP38-induced increase in [Ca2+]i in satellite cells; however, this was partly inhibited in neurons. U73122 or xestospongin C treatment completely and partly abrogated [Ca2+]i changes in satellite cells and in neurons, respectively, whereas VPAC1R and VPAC2R agonists increased [Ca2+]i in satellite cells only. This is the first report demonstrating the expression of PACAPRs specifically, VPAC1 and VPAC2 in SCG and providing evidence for PACAP38-induced [Ca2+]i changes in both satellite cells and neurons via Ca2+ mobilization.</p>

収録刊行物

  • Biomedical Research

    Biomedical Research 38 (2), 99-109, 2017

    バイオメディカルリサーチプレス

参考文献 (50)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ